Patrick N Harter

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Acta neuropathologica

Neuropathology and applied neurobiology

Neuro-oncology advances

The Journal of biological chemistry

Goethe Univeristy Medical School, Frankfurt am Main

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Goethe Univeristy Medical School, Frankfurt am Main Oct 15 2008

Germany

Senior Physician, Vice Director / PD Dr. :: Edinger-Institute

Publications

Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Lucas Hoffmann, Roland Coras, Katja Kobow, Javier A López-Rivera, Dennis Lal, Costin Leu, Imad M Najm, Peter Nürnberg, Jochen Herms, Patrick N Harter, Christian G Bien, Thilo Kalbhenn, Markus Müller, Tom Pieper, Till S Hartlieb, Manfred Kudernatsch, Hajo M Hamer, Sebastian Brandner, Karl Roessler, Ingmar Bluemcke, Samir Jabari
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta neuropathologica (2023)
Lucas Hoffmann, Roland Coras, Katja Kobow, Javier A López-Rivera, Dennis Lal, Costin Leu, Imad M Najm, Peter Nürnberg, Jochen Herms, Patrick N Harter, Christian G Bien, Thilo Kalbhenn, Markus Müller, Tom Pieper, Till S Hartlieb, Manfred Kudernatsch, Hajo M Hamer, Sebastian Brandner, Karl Roessler, Ingmar Bluemcke, Samir Jabari
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta neuropathologica (2023)
Lucas Hoffmann, Roland Coras, Katja Kobow, Javier A López-Rivera, Dennis Lal, Costin Leu, Imad M Najm, Peter Nürnberg, Jochen Herms, Patrick N Harter, Christian G Bien, Thilo Kalbhenn, Markus Müller, Tom Pieper, Till S Hartlieb, Manfred Kudernatsch, Hajo M Hamer, Sebastian Brandner, Karl Roessler, Ingmar Bluemcke, Samir Jabari
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta neuropathologica (2023)
Lucas Hoffmann, Roland Coras, Katja Kobow, Javier A López-Rivera, Dennis Lal, Costin Leu, Imad M Najm, Peter Nürnberg, Jochen Herms, Patrick N Harter, Christian G Bien, Thilo Kalbhenn, Markus Müller, Tom Pieper, Till S Hartlieb, Manfred Kudernatsch, Hajo M Hamer, Sebastian Brandner, Karl Roessler, Ingmar Bluemcke, Samir Jabari
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta neuropathologica (2023)
Pia S Zeiner, Katharina Filipski, Natalie Filmann, Marie-Thérèse Forster, Martin Voss, Emmanouil Fokas, Ulrich Herrlinger, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With Glioma. Neurology 98 (20) (2022)
Irene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, Aleksandra Nevmerzhitskaya, Alexander Schäffer, Ivan-Maximiliano Kur, Ewelina Czlonka, Carolin Wachtel, Ioanna Tsoukala, Luise Müller, Anna-Lena Schäfer, Maresa Weitmann, Petra Dinse, Emily Alberto, Michèle C Buck, Jonathan J M Landry, Bianka Baying, Julia Slotta-Huspenina, Jenny Roesler, Patrick N Harter, Anne-Sophie Kubasch, Jörn Meinel, Eiman Elwakeel, Elisabeth Strack, Christine Tran Quang, Omar Abdel-Wahab, Marc Schmitz, Andreas Weigert, Tobias Schmid, Uwe Platzbecker, Vladimir Benes, Jacques Ghysdael, Halvard Bonig, Katharina S Götze, Carla V Rothlin, Sourav Ghosh, Hind Medyouf
AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia. Cancer discovery 11 (11) (2021)
Naita M Wirsik, Jakob Ehlers, Lisa Mäder, Elena I Ilina, Anna-Eva Blank, Anne Grote, Friedrich Feuerhake, Peter Baumgarten, Kavi Devraj, Patrick N Harter, Michel Mittelbronn, Ulrike Naumann
TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma. Neuropathology and applied neurobiology 47 (6) (2021)
Martin Voss, Katharina Johanna Wenger, Nina von Mettenheim, Jörg Bojunga, Manuela Vetter, Bianca Diehl, Kea Franz, Ruediger Gerlach, Michael W Ronellenfitsch, Patrick N Harter, Elke Hattingen, Joachim P Steinbach, Claus Rödel, Johannes Rieger
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European journal of nutrition (2021)
Yannick Braun, Katharina Filipski, Simon Bernatz, Peter Baumgarten, Bastian Roller, Jenny Zinke, Pia S Zeiner, Elena Ilina, Christian Senft, Michael W Ronellenfitsch, Karl H Plate, Oliver Bähr, Elke Hattingen, Joachim P Steinbach, Michel Mittelbronn, Patrick N Harter
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma. Neuropathology and applied neurobiology 47 (3) (2020)
Martha Foltyn, Anna-Luisa Luger, Nadja I Lorenz, Benedikt Sauer, Michel Mittelbronn, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. British journal of cancer 120 (5) (2019)
Mariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, Kathleen Sommer, Oliver Bähr, Joachim P Steinbach, Christian Senft, Volker Seifert, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina Deckert, Andreas H Scheel, Reinhard Büttner, Oliver M Grauer, Cornelia Brendle, Ghazaleh Tabatabai, Patrick N Harter, Stefan Günther, Kavi Devraj, Karl H Plate, Yvonne Reiss
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF. Cancer immunology research 7 (12) (2019)
Ines Bruns, Benedikt Sauer, Michael C Burger, Jule Eriksson, Ute Hofmann, Yannick Braun, Patrick N Harter, Anna-Luisa Luger, Michael W Ronellenfitsch, Joachim P Steinbach, Johannes Rieger
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells. The Journal of biological chemistry 294 (9) (2018)
Michael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P Steinbach, Manfred Westphal, Patrick N Harter
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma. Acta neuropathologica communications 6 (1) (2018)

Patrick N Harter.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick N Harter